Inhibrx Biosciences, Inc. (INBX)
101.32
-9.25
(-8.37%)
USD |
NASDAQ |
May 22, 16:00
101.37
+0.05
(+0.05%)
After-Hours: 20:00
Inhibrx Biosciences Total Assets (Quarterly) : 183.97M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Merck & Co., Inc. | 128.68B |
| Biogen, Inc. | 29.48B |
| Catalyst Pharmaceuticals, Inc. | 1.148B |
| Inovio Pharmaceuticals, Inc. | 49.78M |
| Capricor Therapeutics, Inc. | 326.28M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 205.00M |
| Shareholders Equity (Quarterly) | -21.04M |
| Debt to Equity Ratio | -8.600 |
| Current Ratio | 6.463 |
| Net Debt Paydown Yield | -3.52% |